SFX by Ex Libris Inc.

Title:	Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Source:	Nature [0028-0836] Wong, T N yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Pulè, Martin A A. "A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells." Molecular therapy 12.5 (2005): 933-41.
description	2.	Bieging, Kathryn T. "Unravelling mechanisms of p53-mediated tumour suppression." Nature Reviews. Cancer 14.5 (2014): 359-370.
description	3.	Surget, S. "Uncovering the role of p53 splice variants in human malignancy: a clinical perspective." OncoTargets and therapy 7.default (2013): 57-67.
description	4.	Ziegelberger, G. "Childhood leukemia – Risk factors and the need for an interdisciplinary research agenda." Progress in biophysics and molecular biology 107.3 (2011): 312-314.
description	5.	Check-Hayden, E. "On the origin of deleterious mutations." Nature 451.7181 (2008): 876-876.
description	6.	Dryja, S H P. "A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma." Nature 323.6089 (1986): 643-6.
description	7.	Vousden, Karen H. "Mutant p53 in Cancer: New Functions and Therapeutic Opportunities." Cancer cell 25.3 (2014): 304-317.
description	8.	Hill, R. "PTEN, stem cells, and cancer stem cells." The Journal of biological chemistry 284.18 (2008): 11755-11759.
description	9.	Weinberg, Robert A. "Hallmarks of cancer: the next generation." Cell 144.5 (2011): 646-674.
description	10.	Kroemer, G. "Cytoplasmic functions of the tumour suppressor p53." Nature 458.7242 (2009): 1127-30.
description	11.	Lane, D. P. "T antigen is bound to a host protein in SV40-transformed cells." Nature 278.5701 (1979): 261-3.
description	12.	McNally, Richard J Q J. "Cross-space-time clustering of childhood cancer in Great Britain: Evidence for a common aetiology." International journal of cancer 134.1 (2013): 136-143.
description	13.	Vanderstraeten, J. "Health effects of extremely low-frequency magnetic fields: reconsidering the melatonin hypothesis in the light of current data on magnetoreception." Journal of applied toxicology 32.12 (2012): 952-958.
description	14.	Savoldo, B. "CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients." The Journal of clinical investigation 121.5 (2011): 1822-1826.
description	15.	Rossig, C. "Target Antigen Expression on a Professional Antigen-Presenting Cell Induces Superior Proliferative Antitumor T-Cell Responses via Chimeric T-Cell Receptors." Journal of immunotherapy 29.1 (2006): 21-31.
description	16.	Pizzitola, I. "In Vitro Comparison of Three Different Chimeric Receptor-Modified Effector T-Cell Populations for Leukemia Cell Therapy." Journal of immunotherapy 34.6 (2011): 469-479.
description	17.	Beecham, E J J. "Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and death." Journal of immunotherapy (2000): 631-42.
description	18.	Liu, Q. "A heat shock protein gene (hsp22.4) from Chaetomium globosum confers heat and Na2CO3 tolerance to yeast." Applied microbiology and biotechnology 77.4 (2007): 901-8.
description	19.	Wilkie, S. "Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor." The journal of immunology 180.7 (2008): 4901-9.
description	20.	Weisz, L. "Transcription regulation by mutant p53." Oncogene 26.15 (2007): 2202-2211.